| P50 | author | Christopher M Maulucci | Q116482360 |
| P2093 | author name string | Aaron S Dumont | |
| | Christopher Carr | |
| | Aimee Aysenne | |
| | Cuong J Bui | |
| | Richard M Zweifler | |
| | Mansour Mathkour | |
| | Tyler Scullen | |
| | Adam Beighley | |
| | Cassidy Werner | |
| | Joseph R Keen | |
| | Tyler Zeoli | |
| | Mitchell D Kilgore | |
| P2860 | cites work | ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia | Q24538811 |
| | Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature | Q33432598 |
| | Possible central nervous system infection by SARS coronavirus | Q35879760 |
| | Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) | Q35905508 |
| | Neurological manifestations in severe acute respiratory syndrome. | Q36298572 |
| | Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. | Q36804585 |
| | Angiotensin-converting enzyme 2 in the brain: properties and future directions | Q37155907 |
| | Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans | Q38195243 |
| | Neurological Complications during Treatment of Middle East Respiratory Syndrome | Q40106479 |
| | Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children | Q40365487 |
| | Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 |
| | Detection of coronavirus RNA and antigen in multiple sclerosis brain | Q41121992 |
| | Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. | Q42020947 |
| | Neuromuscular disorders in severe acute respiratory syndrome | Q45144705 |
| | Prognostic Value of Serum D-Dimer in Noncardioembolic Ischemic Stroke | Q48332769 |
| | Peripheral nerve disease in SARS:: report of a case. | Q51637346 |
| | Axonal Transport Enables Neuron-to-Neuron propagation of HCoV-OC43 | Q59358408 |
| | Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients | Q80192869 |
| | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 |
| | Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? | Q84316149 |
| | A pneumonia outbreak associated with a new coronavirus of probable bat origin | Q84367633 |
| | Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 |
| | A Novel Coronavirus from Patients with Pneumonia in China, 2019 | Q86729469 |
| | Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding | Q86735535 |
| | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Q87412594 |
| | The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients | Q87716536 |
| | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation | Q89108866 |
| | Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series | Q89787863 |
| | Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China | Q89796088 |
| | Clinical Characteristics of Coronavirus Disease 2019 in China | Q89934806 |
| | Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease | Q89969798 |
| | Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China | Q90133538 |
| | Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms | Q90298818 |
| | Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers | Q90626000 |
| | Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020 | Q90664174 |
| | Advice on Standardized Diagnosis and Treatment for Spinal Diseases during the Coronavirus Disease 2019 Pandemic | Q90722244 |
| | Migraine Care in the Era of COVID-19: Clinical Pearls and Plea to Insurers | Q90753718 |
| | Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension | Q90757765 |
| | Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak | Q90758874 |
| | Nervous system involvement after infection with COVID-19 and other coronaviruses | Q91512172 |
| | Medical Masks vs N95 Respirators for Preventing COVID-19 in Health Care Workers A Systematic Review and Meta-Analysis of Randomized Trials | Q91562088 |
| | Kidney disease is associated with in-hospital death of patients with COVID-19 | Q91567279 |
| | Precautions for Operating Room Team Members during the COVID-19 Pandemic | Q91568655 |
| | Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | Q91586974 |
| | A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2 | Q91598863 |
| | Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review | Q91706276 |
| | Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis | Q91727901 |
| | Acute stroke management pathway during Coronavirus-19 pandemic | Q91748143 |
| | Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission | Q91758689 |
| | High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation | Q91765372 |
| | Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China | Q91802849 |
| | Editorial. Early lessons in the management of COVID-19 for the pediatric neurosurgical community from the leadership of the American Society of Pediatric Neurosurgeons | Q91809682 |
| | Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic | Q91817798 |
| | Letter: Academic Neurosurgery Department Response to COVID-19 Pandemic: The University of Miami/Jackson Memorial Hospital Model | Q91821678 |
| | Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019 | Q91952884 |
| | Society of NeuroInterventional Surgery recommendations for the care of emergent neurointerventional patients in the setting of covid-19 | Q91969096 |
| | Letter to the editor by Dobran Mauro, Paracino Riccardo, and Iacoangeli Maurizio regarding "Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy." Zoia C, Bongetta D, Veiceschi P, Cenzato M, Di Meco F, Locatelli D, Boeris | Q92026218 |
| | Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy | Q93199728 |
| P921 | main subject | neurological disorder | Q3339235 |
| | COVID-19 | Q84263196 |
| P577 | publication date | 2020-05-06 | |
| | 2020-07-01 | |
| P1433 | published in | World Neurosurgery | Q26853866 |
| P1476 | title | Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community | |